৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Quantity:
Products
Payment
Delivery
Indications
Lacomax is indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
Lacomax is indicated for adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.
Pharmacology
It is proposed that lacosamide's inhibition of sodium channels is responsible for analgesia. Lacosamide may be selective for inhibiting depolarized neurons rather than neurons with normal resting
potentials. Pain and nociceptor hyperexcitability are associated with neural membrane depolarization. Lacosamide binds to collapsin response mediator protein-2 (CRMP-2), a phosphoprotein which is
expressed primarily in the nervous system and is involved in neuronal differentiation and control of axonal outgrowth. The role CRMP-2 of binding in seizure control is hasn't been elucidated.
The precise mechanism by which Lacosamide exerts its anti-epileptic effects in humans remains to be fully elucidated. In vitro electrophysiological studies have shown that Lacosamide selectively
enhances slow inactivation of voltage-gated sodium channels, resulting in stabilization of hyperexcitable neuronal membranes and inhibition of repetitive neuronal firing.
Dosage & Administration
Recommended Dosages for Partial-Onset Seizures (Monotherapy or Adjunctive Therapy) in Patients 1 Month and Older, and for Primary Generalized Tonic-Clonic Seizures (Adjunctive Therapy) in
Patients 4 Years of Age and Older.
Age and Body Weight
Initial Dosage
Titration
(Incremental Steps)
Maintenance Dosage
Adults (≥17 years)
Increase by 50 mg
twice daily
(100 mg per day)
every week
Pediatric patients (≥50 kg)
Monotherapy:
100 mg twice daily
(200 mg per day)
Adjunctive therapy:
50 mg twice daily
(100 mg per day)
50 mg twice daily
(100 mg per day)
Monotherapy:
150-200 mg twice daily
(300-400 mg per day)
Adjunctive therapy:
100-200 mg twice daily
(200-400 mg per day)
Pediatric patients (30-50 kg)
Pediatric patients (6-30 kg)
1 mg/kg twice daily
(2 mg/kg per day)
Increase by 1 mg/kg
twice daily
(2 mg/kg/day)
every week
Pediatric patients <6 kg)
2-4 mg/kg twice daily
[4-8 mg/kg/day)
3-6 mg/kg twice daily
(6-12 mg/kg/day)
3.75-7.5 mg/kg twice daily
(7.5-15 mg/kg/day)
Lacosamide tablets and oral solution may be taken with or without food.
Interaction
Dose reduction of Lacomax may be necessary in patients with renal or hepatic impairment who are taking strong inhibitors of CYP3A4 & CYP2C9. Lacomax should be used with caution in patients who
are on concomitant medications that affect cardiac conduction (sodium channel blockers, beta-blockers, calcium channel blockers, potassium channel blockers) including those that prolong PR interval
(sodium channel blocking AEDs)






Lacosamide is an anti-epileptic (anticonvulsant) medicine used to control seizures. It works by enhancing the slow inactivation of voltage-gated sodium channels in the brain, which helps stabilize overactive nerve signaling and prevent abnormal electrical activity.
Lacosamide is used in partial-onset seizures in epilepsy patients. It helps reduce seizure frequency, improve neurological stability, and may be used alone or in combination with other anti-epileptic drugs.
